BTW, you example of a dangerous drug causing deaths is right on. Anybody that tried to inject me with rat poison better have a long stride if ever I recovered enough to inflict punishment.
(HEPERIN).
But then, I have been hospitalized only once way back in the fifties...for a broken foot.
Crow3, if you said "What is a decimal position or two amongst friends?" I would no longer be shocked at what you type.
Look, the ValiMed G4 system is out, and the ValiMed G4 system has been discussed by professionals and it has been described in ASHP presentations, and the ValiMed G4 system will again be available at the upcoming trade shows with thousands of pharmacy pros and decision makers gathered for the respective events.
I've had the tremendous opportunity to speak face-to-face with PharmD's that actually use earlier generation ValiMed systems. I've had the tremendous opportunity to gain a real understanding of the importance of this disruptive technology being translated from the development environment to the real world. These things take time, and I believe CDEX is at the threshold and will gain significant attention. I am very confident the right pharmacy decision makers will have what they need to appreciate the ValiMed G4 system. It is unique. We shall see how valuable it will be for shareholders based upon usage, client announcements, third party evaluation, etc etc. Should be fun based upon this...
CHEMICAL AND MOLECULAR IDENTIFICATION AND QUANTIFICATION SYSTEM UTILIZING ENHANCED PHOTOEMISSION SPECTROSCOPY
United States Patent Application 20130120741
The photoelectric detection processes include Raman scattering, fluorescence and spectral reflection. The EPS system uses all three processes to generate spectral data that is then combined to derive a target signature.
weighting the spectral data from each process
the laser generates a signal having a wavelength between 500 nm and 850 nm
the processing step includes adjusting the spectrum data in accordance with a container enclosing the target
provide the capability of identifying individual components of a mixture or compound having more than one substance
Other materials identifiable by the disclosed embodiments include body fluids, such as blood, urine, saliva, other secretions, and the like. Samples of body fluids may be examined to determine levels of drugs or other chemicals
Another application for the disclosed embodiments may include determining the potency of a drug or group of drugs over a period of time. The "decay" or potency degradation over time of the amount of a material within a combination of substances may be determined using the disclosed embodiments. The molecular analysis and determination may determine any breakdown of the target substance over time.
The disclosed system includes a unique configuration that allows novel data manipulation to provide improved results in substance identification.
News 
Market Data 
Discover 
